{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:52:25Z","timestamp":1787701945463,"version":"build-2784847793"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Cangzhou Science and Technology Research and Development Plan","award":["1213018ZD"],"award-info":[{"award-number":["1213018ZD"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12957-018-1350-5","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T11:15:30Z","timestamp":1520248530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Analysis of prognostic factors of patients with malignant peritoneal mesothelioma"],"prefix":"10.1186","volume":"16","author":[{"given":"Wenjie","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunna","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,5]]},"reference":[{"key":"1350_CR1","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ygyno.2005.06.033","volume":"99","author":"AH Picklesimer","year":"2005","unstructured":"Picklesimer AH, Zanagnolo V, Niemann TH, Eaton LA, Copeland LJ. Case report: malignant peritoneal mesothelioma in two siblings. Gynecol Oncol. 2005;99:512\u20136.","journal-title":"Gynecol Oncol"},{"key":"1350_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.gcb.2010.07.016","volume":"35","author":"H Sharma","year":"2011","unstructured":"Sharma H, Bell I, Schofield J, Bird G. Primary peritoneal mesothelioma: case series and literature review. Clin Res Hepatol Gastroenterol. 2011;35:55\u20139.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"1350_CR3","first-page":"599","volume":"52","author":"SC Wei","year":"2013","unstructured":"Wei SC, Zheng GQ. Retrospective analysis of 162 patients with malignant peritoneal mesothelioma in Cangzhou residents. Chin J Intern Med. 2013;52:599\u2013601.","journal-title":"Chin J Intern Med"},{"key":"1350_CR4","doi-asserted-by":"publisher","first-page":"5805","DOI":"10.1158\/1078-0432.CCR-10-2245","volume":"16","author":"SC Kao","year":"2010","unstructured":"Kao SC, Pavlakis N, Harvie R, Vardy JL, Boyer MJ, Van Zandwik N, et al. High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res. 2010;16:5805\u201313.","journal-title":"Clin Cancer Res"},{"key":"1350_CR5","doi-asserted-by":"publisher","first-page":"602","DOI":"10.4067\/S0034-98872013000500008","volume":"141","author":"GI Urrejola","year":"2013","unstructured":"Urrejola GI, Bambs CE, Espinoza MA, Gellona J, Z\u00fa\u00f1iga AM, Molina ME, et al. An elevated neutrophil\/lymphocyte ratio is associated with poor prognosis in stage II resected colon cancer. Rev Med Chil. 2013;141:602\u20138.","journal-title":"Rev Med Chil"},{"key":"1350_CR6","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.7314\/APJCP.2014.15.6.2647","volume":"15","author":"Y Ozdemir","year":"2014","unstructured":"Ozdemir Y, Akin ML, Sucullu I, Balta AZ, Yucel E. Pretreatment neutrophil\/lymphocyte ratio as a prognostic aid in colorectal cancer. Asian Pac J Cancer Prev. 2014;15:2647\u201350.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1350_CR7","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s12032-012-0432-4","volume":"30","author":"B Azab","year":"2013","unstructured":"Azab B, Shah N, Radbel J, Tan P, Bhatt V, Vonfrolio S, et al. Pretreatment neutrophil\/lymphocyte ratio is superior to platelet\/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients. Med Oncol. 2013;30:432\u201342.","journal-title":"Med Oncol"},{"key":"1350_CR8","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1038\/bjc.2013.135","volume":"108","author":"J Szkandera","year":"2013","unstructured":"Szkandera J, Absenger G, Liegl-Atzwanger B, Pichler M, Stotz M, Samonigg H, et al. Elevated preoperative neutrophil\/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients. Br J Cancer. 2013;108:1677\u201383.","journal-title":"Br J Cancer"},{"key":"1350_CR9","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.urology.2011.11.070","volume":"79","author":"T Gondo","year":"2012","unstructured":"Gondo T, Nakashima J, Ohno Y, Choichiro O, Horiguchi Y, Namiki K, et al. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy. Urology. 2012;79:1085\u201391.","journal-title":"Urology"},{"key":"1350_CR10","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.eururo.2011.01.034","volume":"59","author":"TM Morgan","year":"2011","unstructured":"Morgan TM, Tang D, Stratton KL, Barocas DA, Anderson CB, Gregg JR, et al. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. Eur Urol. 2011;59:923\u20138.","journal-title":"Eur Urol"},{"key":"1350_CR11","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s00595-011-0061-0","volume":"42","author":"T Nozoe","year":"2012","unstructured":"Nozoe T, Kohno M, Iguchi T, Mori E, Maeda T, Matsukuma A, et al. The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma. Surg Today. 2012;42:532\u20135.","journal-title":"Surg Today"},{"key":"1350_CR12","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1053\/ejso.2002.1257","volume":"28","author":"T Nozoe","year":"2002","unstructured":"Nozoe T, Kimura Y, Ishida M, Saeki H, Korenaga D, Sugimachi K. Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma. Eur J Surg Oncol. 2002;28:396\u2013400.","journal-title":"Eur J Surg Oncol"},{"key":"1350_CR13","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.1007\/s13277-014-1938-5","volume":"35","author":"ZH Yao","year":"2014","unstructured":"Yao ZH, Tian GY, Yang SX, Wan YY, Kang YM, Liu QH, et al. Serum albumin as a significant prognostic factor in patients with malignant pleural mesothelioma. Tumour Biol. 2014;35:6839\u201345.","journal-title":"Tumour Biol"},{"key":"1350_CR14","first-page":"631","volume":"102","author":"J Ruiz-Tovar","year":"2010","unstructured":"Ruiz-Tovar J, Martin-Perez E, Fernandez-Contreras ME, Reguero-Callejas ME, Gamallo-Amat C. Impact of preoperative levels of hemoglobin and albumin on the survival of pancreatic carcinoma. Rev Esp Enferm. Dig. 2010;102:631\u20136.","journal-title":"Rev Esp Enferm. Dig"},{"key":"1350_CR15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1245\/s10434-006-9093-x","volume":"14","author":"LF Onate-Ocana","year":"2007","unstructured":"Onate-Ocana LF, Aiello-Crocifoglio V, Gallardo-Rincon D, Herrera-Goepfert R, Brom-Valladares R, Carrillo JF, et al. Serum albumin as a significant prognostic factor for patients with gastric carcinoma. Ann Surg Oncol. 2007;14:381\u20139.","journal-title":"Ann Surg Oncol"},{"key":"1350_CR16","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/hed.23357","volume":"36","author":"G Li","year":"2014","unstructured":"Li G, Gao J, Liu ZG, Tao YL, Xu BQ, Tu ZW, et al. Influence of pretreatment ideal body weight percentile and albumin on prognosis of nasopharyngeal carcinoma: long-term outcomes of 512 patients from a single institution. Head Neck. 2014;36:660\u20136.","journal-title":"Head Neck"},{"key":"1350_CR17","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.urology.2012.10.055","volume":"81","author":"JW Lambert","year":"2013","unstructured":"Lambert JW, Ingham M, Gibbs BB, Given RW, Lance RS, Riggs SB. Using preoperative albumin levels as a surrogate marker for outcomes after radical cystectomy for bladder cancer. Urology. 2013;81:587\u201392.","journal-title":"Urology"},{"key":"1350_CR18","doi-asserted-by":"publisher","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","volume":"137","author":"AN Husain","year":"2013","unstructured":"Husain AN, Colby T, Ordonez N, Krausz T, Attanoos R, Beasley MB, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the international mesothelioma interest group. Arch Pathol Lab Med. 2013;137:647\u201367.","journal-title":"Arch Pathol Lab Med"},{"key":"1350_CR19","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1097\/JTO.0b013e31822a3740","volume":"6","author":"SC Kao","year":"2011","unstructured":"Kao SC, Klebe S, Henderson DW, Reid G, Chatfield M, Armstrong NJ, et al. Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy. J Thorac Oncol. 2011;6:1923\u20139.","journal-title":"J Thorac Oncol"},{"key":"1350_CR20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11547-015-0609-y","volume":"121","author":"WJ Yin","year":"2016","unstructured":"Yin WJ, Zheng GQ, Chen YF, Chen DQ, Sun NN, Yang YX, et al. CT differentiation of malignant peritoneal mesothelioma and tuberculous peritonitis. Radiol Med. 2016;121:253\u201360.","journal-title":"Radiol Med"},{"key":"1350_CR21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/jgh.13260","volume":"31","author":"YF Liang","year":"2016","unstructured":"Liang YF, Zheng GQ, Chen YF, Song H, Yin WJ, Zhang L. CT differentiation of diffuse malignant peritoneal mesothelioma and peritoneal carcinomatosis. J Gastroenterol Hepatol. 2016;31:709\u201315.","journal-title":"J Gastroenterol Hepatol"},{"key":"1350_CR22","first-page":"1","volume":"2016","author":"SS Su","year":"2016","unstructured":"Su SS, Zheng GQ, Liu YG, Chen YF, Song ZW, Yu SJ, et al. Malignant peritoneum mesothelioma with hepatic involvement: a single institution experience in 5 patients and review of the literature. Gastroenterol Res Pract. 2016;2016:1\u201312.","journal-title":"Gastroenterol Res Pract"},{"key":"1350_CR23","first-page":"224","volume":"2","author":"E Skammeritz","year":"2011","unstructured":"Skammeritz E, Omland LH, Johansen JP, Omland O. Asbestos exposure and survival in malignant mesothelioma: a description of 122 consecutive cases at an occupational clinic. Int J Occup Environ Med. 2011;2:224\u201336.","journal-title":"Int J Occup Environ Med"},{"key":"1350_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1245\/s10434-009-0756-2","volume":"17","author":"D Baratti","year":"2010","unstructured":"Baratti D, Kusamura S, Cabras AD, Laterza B, Balestra MR, Deraco M. Lymph node metastases in diffuse malignant peritoneal mesothelioma. Ann Surg Oncol. 2010;17:45\u201353.","journal-title":"Ann Surg Oncol"},{"key":"1350_CR25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/his.12807","volume":"68","author":"AM Krasinskas","year":"2016","unstructured":"Krasinskas AM, Borczuk AC, Hartman DJ, Chabot JA, Taub RN. Mogal A1, et al. prognostic significance of morphological growth patterns and mitotic index of epithelioid malignant peritoneal mesothelioma. Histopathology. 2016;68:729\u201337.","journal-title":"Histopathology"},{"key":"1350_CR26","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00432-013-1408-2","volume":"139","author":"K Pillai","year":"2013","unstructured":"Pillai K, Pourgholami MH, Chua TC, Morris DL. Oestrogen receptors are prognostic factors in malignant peritoneal mesothelioma. J Cancer Res Clin Oncol. 2013;139:987\u201394.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1350_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.lungcan.2007.12.025","volume":"61","author":"OD Roe","year":"2008","unstructured":"Roe OD, Creaney J, Lundgren S, Larsson E, Sandeck H, Boffetta P, et al. Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case-control study. Lung Cancer. 2008;61:235\u201343.","journal-title":"Lung Cancer"},{"key":"1350_CR28","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1245\/s10434-013-3077-4","volume":"20","author":"J Hommell-Fontaine","year":"2013","unstructured":"Hommell-Fontaine J, Isaac S, Passot G, Decullier E, Traverse-Glehen A, Cotte E, et al. Malignant peritoneal mesothelioma treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is GLUT1 expression a major prognostic factor? A preliminary study. Ann Surg Oncol. 2013;20:3892\u20138.","journal-title":"Ann Surg Oncol"},{"key":"1350_CR29","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1016\/j.ejca.2011.03.028","volume":"47","author":"MJ Proctor","year":"2011","unstructured":"Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O\u2019Reilly DS, et al. A comparison of inflamemation-based prognostic scores in patients with cancer. A Glasgow inflammation outcome study. Eur J Cancer. 2011;47:2633\u201341.","journal-title":"Eur J Cancer"},{"key":"1350_CR30","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.7314\/APJCP.2014.15.5.2061","volume":"15","author":"YB Cihan","year":"2014","unstructured":"Cihan YB, Ozturk A, Mutlu H. Relationship between prognosis and neutrophil: lymphocyte and platelet: lymphocyte ratios in patients with malignant pleural mesotheliomas. Asian Pac J Cancer Prev. 2014;15:2061\u20137.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1350_CR31","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s13014-014-0295-2","volume":"9","author":"L Shen","year":"2014","unstructured":"Shen L, Zhang H, Liang L, Li G, Fan M, Wu Y, et al. Baseline neutrophil-lymphocyte ratio (\u22652.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation. Radiat Oncol. 2014;9:295.","journal-title":"Radiat Oncol"},{"key":"1350_CR32","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.0894-0959.2004.17603.x","volume":"17","author":"BR Don","year":"2004","unstructured":"Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17:432\u20137.","journal-title":"Semin Dial"},{"key":"1350_CR33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.tips.2011.03.011","volume":"32","author":"RE Favoni","year":"2011","unstructured":"Favoni RE, Florio T. Combined chemotherapy with cytotoxic and targeted compounds for the management of human malignant pleural mesothelioma. Trends Pharmacol Sci. 2011;32:463\u201379.","journal-title":"Trends Pharmacol Sci"},{"key":"1350_CR34","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ejso.2006.03.009","volume":"32","author":"R Garcia-Carbonero","year":"2006","unstructured":"Garcia-Carbonero R, Paz-Ares L. Systemic chemotherapy in the management of malignant peritoneal mesothelioma. Eur J Surg Oncol. 2006;32:676\u201381.","journal-title":"Eur J Surg Oncol"},{"key":"1350_CR35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3816\/CLC.2005.n.020","volume":"7","author":"PA J\u00e4nne","year":"2005","unstructured":"J\u00e4nne PA, Wozniak AJ, Belani CP, Keohan ML, Ross HJ, Polikoff JA, et al. Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program. Clin Lung Cancer. 2005;7:40\u20136.","journal-title":"Clin Lung Cancer"},{"key":"1350_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1245\/s10434-006-9169-7","volume":"14","author":"TD Yan","year":"2007","unstructured":"Yan TD, Brun EA, Cerruto CA, Haveric N, Chang D, Sugarbaker PH. Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma. Ann Surg Oncol. 2007;14:41\u20139.","journal-title":"Ann Surg Oncol"},{"key":"1350_CR37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4240\/wjgs.v1.i1.38","volume":"1","author":"S Munkholm-Larsen","year":"2009","unstructured":"Munkholm-Larsen S, Cao CQ, Yan TD. Malignant peritoneal mesothelioma. World J Gastrointest Surg. 2009;1:38\u201348.","journal-title":"World J Gastrointest Surg"},{"key":"1350_CR38","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.ejso.2006.05.009","volume":"32","author":"TD Yan","year":"2006","unstructured":"Yan TD, Yoo D, Sugarbaker PH. Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma. Eur J Surg Oncol. 2006;32:948\u201353.","journal-title":"Eur J Surg Oncol"},{"key":"1350_CR39","doi-asserted-by":"publisher","first-page":"433","DOI":"10.4149\/neo_2014_053","volume":"61","author":"H Kaya","year":"2014","unstructured":"Kaya H, Sezg\u0131 C, Tanr\u0131kulu AC, Taylan M, Abakay O, Sen HS, et al. Prognostic factors influencing survival in 35 patients with malignant peritoneal mesothelioma. Neoplasma. 2014;61:433\u20138.","journal-title":"Neoplasma"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-018-1350-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T00:37:01Z","timestamp":1551746221000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-018-1350-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,5]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1350"],"URL":"https:\/\/doi.org\/10.1186\/s12957-018-1350-5","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,5]]},"assertion":[{"value":"19 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all included individual participants or their authorized families.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"44"}}